tm logo

Monitor this mark

View On USPTO

OXNIMBI
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 16 Oct 2024

Last Applicant/ Owned by

Apnimed, Inc.

39 John F. Kennedy Street, 4th Floor

Cambridge

MA

02138

Serial Number

97715318 filed on 13th Dec 2022

Registration Number

N/A

Correspondent Address

Sean McConnell

Sean McConnell TROUTMAN PEPPER HAMILTON SANDERS LLP

3000 TWO LOGAN SQUARE

PHILADELPHIA, PA 19103

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

OXNIMBI

Pharmaceutical preparations for the treatment of obstructive sleep apnea, symptomatic snoring, and sleep disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of obstructive sleep apnea, symptomatic snoring, and sleep disorders

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97715318

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 145543.00002

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
16th Oct 2024SOU EXTENSION 2 FILED
16th Oct 2024SOU EXTENSION 2 GRANTED
16th Oct 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16th Oct 2024SOU TEAS EXTENSION RECEIVED
23rd Jan 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19th Jan 2024SOU EXTENSION 1 GRANTED
19th Jan 2024SOU EXTENSION 1 FILED
19th Jan 2024SOU TEAS EXTENSION RECEIVED
19th Dec 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
24th Oct 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED